Authors/Disclosures
|
|
No disclosure on file |
|
Kevin Patel, MD
|
No disclosure on file |
|
Mark J. Tramo, MD, PhD
(Mark Tramo, MD)
|
No disclosure on file |
|
|
No disclosure on file |
|
Alice W. Flaherty, MD, PhD
|
No disclosure on file |
|
Kathleen Burger, DO
(MedStar Georgetown University Hospital)
|
Dr. Burger has nothing to disclose. |
|
|
No disclosure on file |
|
Anne B. Young, MD, PhD
(Massachusetts General Hospital)
|
Dr. Young has nothing to disclose. |
|
John D. Bireley, MD
|
Dr. Bireley has nothing to disclose. |
|
Victoria Smith
|
No disclosure on file |
|
Brian C. Healy
|
The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Caterina Mainero, MD, PhD
(Massacgusetts General Hospital)
|
The institution of Dr. Mainero has received research support from Genentech. |
|
Eric Klawiter, MD, FAAN
(Massachusetts General Hospital)
|
Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech. |